Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 120 | $87,304,108 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Mar 2025 16:14 | ANIP | ANI PHARMACEUTICALS INC | DAVIS KRISTA | SVP, CHIEF HR OFFICER | 19 Mar 2025 | Sale | 1,866 | 65 | 121,290 | D |
| 14 Mar 2025 17:28 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Mar 2025 | Sale | 400 | 63.33 | 25,332 | D |
| 10 Mar 2025 20:28 | ANIP | ANI PHARMACEUTICALS INC | DAVIS KRISTA | SVP, CHIEF HR OFFICER | 07 Mar 2025 | Sale | 1,000 | 60.86 | 60,860 | D |
| 07 Mar 2025 16:09 | ANIP | ANI PHARMACEUTICALS INC | GUTWERG ORI | SVP, GENERICS | 05 Mar 2025 | Sale | 300 | 60.03 | 18,009 | D |
| 07 Mar 2025 16:09 | ANIP | ANI PHARMACEUTICALS INC | GUTWERG ORI | SVP, GENERICS | 05 Mar 2025 | Sale | 5,084 | 60 | 305,040 | D |
| 24 Feb 2025 16:33 | ANIP | ANI PHARMACEUTICALS INC | DAVIS KRISTA | SVP, CHIEF HR OFFICER | 21 Feb 2025 | Sale | 1,000 | 60.2 | 60,200 | D |
| 18 Feb 2025 20:12 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Feb 2025 | Sale | 400 | 59.54 | 23,816 | D |
| 13 Jan 2025 16:15 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Jan 2025 | Sale | 400 | 53.92 | 21,568 | D |
| 18 Dec 2024 17:59 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | 17 Dec 2024 | Sale | 7,500 | 55.79 | 418,425 | D |
| 16 Dec 2024 16:20 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Dec 2024 | Sale | 250 | 56.24 | 14,060 | D |
| 12 Dec 2024 17:08 | ANIP | ANI PHARMACEUTICALS INC | DAVIS KRISTA | SVP, CHIEF HR OFFICER | 11 Dec 2024 | Sale | 1,000 | 60 | 60,000 | D |
| 27 Nov 2024 17:38 | ANIP | ANI PHARMACEUTICALS INC | LALWANI NIKHIL | PRESIDENT & CEO | 26 Nov 2024 | Sale | 30,000 | 57.95 | 1,738,500 | D |
| 27 Nov 2024 17:38 | ANIP | ANI PHARMACEUTICALS INC | LALWANI NIKHIL | PRESIDENT & CEO | 26 Nov 2024 | Sale | 3,481 | 58.3 | 202,942 | D |
| 18 Nov 2024 16:03 | ANIP | ANI PHARMACEUTICALS INC | MUTZ CHRISTOPHER | HEAD OF RARE DISEASE | 15 Nov 2024 | Sale | 6,500 | 57.7 | 375,050 | D |
| 14 Nov 2024 16:16 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Nov 2024 | Sale | 250 | 61.36 | 15,340 | D |
| 15 Oct 2024 17:57 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 14 Oct 2024 | Sale | 250 | 57.19 | 14,298 | D |
| 16 Sep 2024 16:50 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Sep 2024 | Sale | 250 | 56.82 | 14,205 | D |
| 14 Aug 2024 08:29 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Aug 2024 | Sale | 250 | 59.62 | 14,905 | D |
| 19 Jul 2024 17:30 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Jul 2024 | Sale | 2,743 | 62 | 170,066 | I |
| 17 Jul 2024 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Jul 2024 | Sale | 14,257 | 63.16 | 900,472 | I |
| 17 Jul 2024 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Jul 2024 | Sale | 22,000 | 64.27 | 1,413,940 | I |
| 17 Jul 2024 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Jul 2024 | Sale | 11,000 | 63.38 | 697,180 | I |
| 15 Jul 2024 16:38 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 12 Jul 2024 | Sale | 250 | 64.91 | 16,228 | D |
| 02 Jul 2024 20:58 | ANIP | ANI PHARMACEUTICALS INC | GASSERT CHAD | SVP - CORP. DEV. & STRATEGY | 01 Jul 2024 | Sale | 20,000 | 63.44 | 1,268,800 | I |
| 24 Jun 2024 16:12 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 21 Jun 2024 | Sale | 20,000 | 58.9 | 1,178,000 | I |
| 20 Jun 2024 19:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 20 Jun 2024 | Sale | 11,447 | 59.86 | 685,217 | I |
| 20 Jun 2024 19:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Jun 2024 | Sale | 10,607 | 60.76 | 644,481 | I |
| 20 Jun 2024 19:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Jun 2024 | Sale | 7,946 | 61.41 | 487,964 | I |
| 14 Jun 2024 17:23 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Jun 2024 | Sale | 250 | 63.8 | 15,950 | D |
| 06 Jun 2024 18:21 | ANIP | ANI PHARMACEUTICALS INC | GUTWERG ORI | SVP, GENERICS | 05 Jun 2024 | Sale | 2,985 | 67 | 199,995 | D |
| 06 Jun 2024 07:34 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | 04 Jun 2024 | Sale | 5,000 | 63.58 | 317,900 | D |
| 04 Jun 2024 18:08 | ANIP | ANI PHARMACEUTICALS INC | GASSERT CHAD | SVP - CORP. DEV. & STRATEGY | 03 Jun 2024 | Sale | 20,000 | 64.41 | 1,288,200 | I |
| 22 May 2024 18:14 | ANIP | ANI PHARMACEUTICALS INC | MUTZ CHRISTOPHER | HEAD OF RARE DISEASE | 21 May 2024 | Sale | 2,000 | 61.61 | 123,220 | D |
| 21 May 2024 17:21 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 20 May 2024 | Sale | 12,855 | 61.81 | 794,568 | I |
| 17 May 2024 18:05 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 May 2024 | Sale | 5,836 | 62.09 | 362,357 | I |
| 17 May 2024 18:05 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 May 2024 | Sale | 16,459 | 63.84 | 1,050,743 | I |
| 17 May 2024 18:05 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 May 2024 | Sale | 14,850 | 65.86 | 978,021 | I |
| 17 May 2024 18:01 | ANIP | ANI PHARMACEUTICALS INC | TANNENBAUM RENEE P | Director | 16 May 2024 | Sale | 2,000 | 63.87 | 127,740 | D |
| 16 May 2024 17:02 | ANIP | ANI PHARMACEUTICALS INC | LALWANI NIKHIL | PRESIDENT & CEO | 14 May 2024 | Sale | 16,669 | 66.1 | 1,101,821 | D |
| 13 May 2024 17:25 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 May 2024 | Sale | 250 | 67.69 | 16,922 | D |
| 03 May 2024 17:48 | ANIP | ANI PHARMACEUTICALS INC | GASSERT CHAD | SVP - CORP. DEV. & STRATEGY | 01 May 2024 | Sale | 20,000 | 66.62 | 1,332,400 | I |
| 22 Apr 2024 18:26 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Apr 2024 | Sale | 16,809 | 65.17 | 1,095,443 | I |
| 22 Apr 2024 18:26 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Apr 2024 | Sale | 10,423 | 64.98 | 677,287 | I |
| 17 Apr 2024 16:33 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Apr 2024 | Sale | 9,520 | 65.4 | 622,608 | I |
| 17 Apr 2024 16:33 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Apr 2024 | Sale | 5,834 | 66.2 | 386,211 | I |
| 17 Apr 2024 16:33 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Apr 2024 | Sale | 7,414 | 66.33 | 491,771 | I |
| 15 Apr 2024 18:28 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 12 Apr 2024 | Sale | 250 | 67.79 | 16,948 | D |
| 02 Apr 2024 18:59 | ANIP | ANI PHARMACEUTICALS INC | GASSERT CHAD | SVP - CORP. DEV. & STRATEGY | 01 Apr 2024 | Sale | 20,000 | 67.25 | 1,345,000 | I |
| 13 Mar 2024 16:48 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Mar 2024 | Sale | 250 | 66.54 | 16,635 | D |
| 13 Mar 2024 16:44 | ANIP | ANI PHARMACEUTICALS INC | GASSERT CHAD | SVP - CORP. DEV. & STRATEGY | 11 Mar 2024 | Sale | 20,000 | 65.81 | 1,316,200 | I |
| 11 Mar 2024 18:43 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 08 Mar 2024 | Sale | 10,000 | 67.17 | 671,700 | I |
| 11 Mar 2024 18:39 | ANIP | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | 11 Mar 2024 | Sale | 7,787 | 65.55 | 510,438 | D |
| 08 Mar 2024 19:25 | ANIP | ANI PHARMACEUTICALS INC | LALWANI NIKHIL | PRESIDENT & CEO | 08 Mar 2024 | Sale | 16,292 | 67.13 | 1,093,682 | D |
| 08 Mar 2024 19:25 | ANIP | ANI PHARMACEUTICALS INC | LALWANI NIKHIL | PRESIDENT & CEO | 06 Mar 2024 | Sale | 28,965 | 65.52 | 1,897,787 | D |
| 07 Mar 2024 21:42 | ANIP | ANI PHARMACEUTICALS INC | MARKEN JAMES G. | SVP OPS & PROD DEV | 07 Mar 2024 | Sale | 24,338 | 66.37 | 1,615,313 | D |
| 07 Mar 2024 21:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 07 Mar 2024 | Sale | 15,085 | 66.35 | 1,000,890 | I |
| 07 Mar 2024 21:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 06 Mar 2024 | Sale | 14,822 | 65.47 | 970,396 | I |
| 07 Mar 2024 21:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 05 Mar 2024 | Sale | 10,093 | 65.35 | 659,578 | I |
| 06 Mar 2024 16:24 | ANIP | ANI PHARMACEUTICALS INC | MUTZ CHRISTOPHER | HEAD OF RARE DISEASE | 05 Mar 2024 | Sale | 5,000 | 66 | 330,000 | D |
| 06 Mar 2024 16:20 | ANIP | ANI PHARMACEUTICALS INC | PERA ANTONIO R | Director | 04 Mar 2024 | Sale | 7,000 | 65.2 | 456,400 | D |
| 13 Feb 2024 20:05 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Feb 2024 | Sale | 250 | 56.04 | 14,010 | D |
| 23 Jan 2024 17:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 23 Jan 2024 | Sale | 15,000 | 56.44 | 846,600 | I |
| 23 Jan 2024 17:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Jan 2024 | Sale | 4,524 | 55.57 | 251,399 | I |
| 23 Jan 2024 17:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 22 Jan 2024 | Sale | 5,692 | 55.95 | 318,467 | I |
| 18 Jan 2024 18:20 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Jan 2024 | Sale | 10,000 | 55.11 | 551,100 | I |
| 18 Jan 2024 18:20 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Jan 2024 | Sale | 9,784 | 55.3 | 541,055 | I |
| 18 Jan 2024 18:20 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Jan 2024 | Sale | 5,000 | 55.63 | 278,150 | I |
| 16 Jan 2024 21:09 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 12 Jan 2024 | Sale | 250 | 56.43 | 14,108 | D |
| 19 Dec 2023 17:44 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Dec 2023 | Sale | 25,000 | 52.65 | 1,316,250 | I |
| 19 Dec 2023 17:44 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Dec 2023 | Sale | 13,026 | 52.44 | 683,083 | I |
| 19 Dec 2023 17:44 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Dec 2023 | Sale | 11,974 | 52.44 | 627,917 | I |
| 11 Dec 2023 17:49 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 11 Dec 2023 | Sale | 250 | 49.21 | 12,302 | D |
| 20 Nov 2023 21:05 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Nov 2023 | Sale | 13,000 | 51 | 663,000 | I |
| 20 Nov 2023 20:58 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Nov 2023 | Sale A | 6,448 | 51.66 | 333,104 | I |
| 20 Nov 2023 20:58 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Nov 2023 | Sale A | 7,647 | 53.64 | 410,185 | I |
| 20 Nov 2023 20:58 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 14 Nov 2023 | Sale A | 22,905 | 53.17 | 1,217,859 | I |
| 16 Nov 2023 18:13 | ANIP | ANI PHARMACEUTICALS INC | DAVIS KRISTA | SVP, CHIEF HR OFFICER | 15 Nov 2023 | Sale | 2,622 | 53.81 | 141,090 | D |
| 16 Nov 2023 18:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Nov 2023 | Sale | 6,448 | 51.66 | 333,104 | I |
| 16 Nov 2023 18:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Nov 2023 | Sale | 7,647 | 53.64 | 410,185 | I |
| 16 Nov 2023 18:11 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 14 Nov 2023 | Sale | 22,095 | 53.17 | 1,174,791 | I |
| 14 Nov 2023 17:04 | ANIP | ANI PHARMACEUTICALS INC | COOK MEREDITH | SR. VP, GENERAL COUNSEL & SEC. | 13 Nov 2023 | Sale | 250 | 52.03 | 13,008 | D |
| 13 Nov 2023 16:02 | ANIP | ANI PHARMACEUTICALS INC | MUTZ CHRISTOPHER | HEAD OF RARE DISEASE | 10 Nov 2023 | Sale | 3,000 | 52.47 | 157,410 | D |
| 19 Oct 2023 16:28 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Oct 2023 | Sale | 6,242 | 57.78 | 360,663 | I |
| 19 Oct 2023 16:28 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Oct 2023 | Sale | 10,000 | 57.06 | 570,600 | I |
| 19 Oct 2023 16:28 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 17 Oct 2023 | Sale | 8,758 | 58.53 | 512,606 | I |
| 17 Oct 2023 16:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 13 Oct 2023 | Sale | 11,937 | 57.58 | 687,332 | I |
| 17 Oct 2023 16:32 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 16 Oct 2023 | Sale | 13,063 | 58.31 | 761,704 | I |
| 03 Oct 2023 20:00 | ANIP | ANI PHARMACEUTICALS INC | GASSERT CHAD | SVP - CORP. DEV. & STRATEGY | 02 Oct 2023 | Sale | 20,000 | 56.48 | 1,129,600 | I |
| 19 Sep 2023 17:14 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 19 Sep 2023 | Sale | 25,333 | 61.23 | 1,551,140 | I |
| 19 Sep 2023 17:14 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 18 Sep 2023 | Sale | 8,425 | 61.64 | 519,317 | I |
| 19 Sep 2023 17:14 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Sep 2023 | Sale | 16,242 | 62.81 | 1,020,160 | I |
| 05 Sep 2023 17:06 | ANIP | ANI PHARMACEUTICALS INC | GASSERT CHAD | SVP - CORP. DEV. & STRATEGY | 01 Sep 2023 | Sale | 20,000 | 64.7 | 1,294,000 | I |
| 30 Aug 2023 16:29 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 29 Aug 2023 | Sale | 25,000 | 63.37 | 1,584,250 | I |
| 30 Aug 2023 16:29 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 28 Aug 2023 | Sale | 25,000 | 63.06 | 1,576,500 | I |
| 25 Aug 2023 16:22 | ANIP | ANI PHARMACEUTICALS INC | GUTWERG ORI | SVP, GENERICS | 23 Aug 2023 | Sale | 2,059 | 62.39 | 128,461 | D |
| 25 Aug 2023 16:22 | ANIP | ANI PHARMACEUTICALS INC | GUTWERG ORI | SVP, GENERICS | 23 Aug 2023 | Sale | 13,502 | 62.39 | 842,390 | D |
| 25 Aug 2023 16:17 | ANIP | ANI PHARMACEUTICALS INC | MARKEN JAMES G. | SVP OPS & PROD DEV | 23 Aug 2023 | Sale | 3,932 | 63 | 247,716 | D |
| 16 Aug 2023 20:00 | ANIP | ANI PHARMACEUTICALS INC | MERIDIAN VENTURE PARTNERS II LP | 10% | 16 Aug 2023 | Sale | 200,000 | 58.5 | 11,700,000 | D |
| 16 Aug 2023 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 15 Aug 2023 | Sale | 22,110 | 61.6 | 1,361,976 | I |
| 16 Aug 2023 19:07 | ANIP | ANI PHARMACEUTICALS INC | SHANMUGAM MUTHUSAMY | HEAD OF R&D, COO-NOVITIUM OPS | 14 Aug 2023 | Sale | 27,890 | 61.15 | 1,705,474 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)